Legal and Regulatory Landscape for Psychedelics Companies Considering “Going Public” in Canada
July 11, 2020
As the psychedelic industry emerges and its benefits are discovered, TheraCann reinvents itself and remains at the forefront of the industry. According to this article, the emerging industry has four categories: Pharmaceutical, Clinic or treatment centers, Nutraceutical/wellness products and Medical tourism/recreational usage.
TheraCann International, as part of the 4th category, provides critical infrastructure as a service (IaaS) leveraging its existing experience in services and disruptive technologies from the industrial hemp and commercial cannabis sectors to ensure that this new sector is able to ramp up industry supply to meet the obvious demand curve in the months / year to follow.